findmyKOL
Clinical trialNCT04440735Active, not recruitingPhase 1/PHASE2Interventional

A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

SponsorKahr MedicalEnrollment125Advanced Solid TumorColorectal CancerNon Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moores Cancer Center, Ucsd

    La Jolla, California, United States

  • University of Colorado Hospital, Anschutz Cancer Pavilion (acp)

    Aurora, Colorado, United States

  • Florida Cancer Specialists

    Lake Mary, Florida, United States

  • Indiana University Simon Cancer Center

    Indianapolis, Indiana, United States

  • Kucc / Kumcri University of Kansas Cancer Center

    Kansas City, Kansas, United States

  • Skcc-Sidney Kimmel Cancer Center Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

  • Upmc Hillman Cancer Center University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Oct 2020
Primary completion
30 Sept 2025
Completion
30 Sept 2025
Last update posted
9 Jan 2025
Registered enrollment
125
Registry id
NCT04440735

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.